Overview
Syed Hassany is a Hematologist and an Oncologist in Muskogee, Oklahoma. Dr. Hassany is rated as an Advanced provider by MediFind in the treatment of Anemia. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Familial Colorectal Cancer, and Bone Marrow Aspiration.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 Rockefeller Dr, Muskogee, OK 74401
Additional Areas of Focus
Dr. Hassany has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Baptist Health Services
Varant Arzoumanian is a Hematologist Oncology specialist and a Hematologist in Fort Smith, Arkansas. Dr. Arzoumanian is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Arzoumanian is currently accepting new patients.
Oklahoma Cancer Specialists And Research Institute, LLC
Ali Moussa is a Hematologist and an Oncologist in Tulsa, Oklahoma. Dr. Moussa is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration.
Oklahoma Cancer Specialists And Research Institute, LLC
Charles Taylor is a Hematologist and an Oncologist in Tulsa, Oklahoma. Dr. Taylor is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Lung Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Colorectal CancerDr. Hassany isDistinguished. Learn about Familial Colorectal Cancer.
- Lung CancerDr. Hassany isDistinguished. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Hassany isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Hassany isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- Adult Immune ThrombocytopeniaDr. Hassany isAdvanced. Learn about Adult Immune Thrombocytopenia.
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Hassany isAdvanced. Learn about Anemia.
- Autoimmune Hemolytic AnemiaDr. Hassany isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Breast CancerDr. Hassany isAdvanced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Hassany isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Hassany isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Acute Eosinophilic PneumoniaDr. Hassany isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Hassany isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Hassany isExperienced. Learn about Acute Myeloid Leukemia (AML).